Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05666245 · ClinicalTrials.gov registry record · NA
DMID 21-0041; Influenza CVD 59000
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT05666245: Completed NA study, sponsored by University of Maryland, Baltimore.
NCT05666245 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05666245, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The primary objective of EMIT-2 is to use a randomized controlled trial (RCT) design to implement interventions which are known to reduce inhalation (airborne) transmission, so that the contribution of transmission by route of aerosols for influenza may be identified.
Primary Outcome
Proportion of recipients with viral confirmation of influenza infection
Interventions
- BEHAVIORAL Personal Protective Equipment (PPE) - Under High Air Hygiene
- BEHAVIORAL No Intervention - Under High Air Hygiene
- BEHAVIORAL Personal Protective Equipment (PPE) - Under Low Air Hygiene
- BEHAVIORAL No Intervention - Under Low Air Hygiene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2023-02-20 |
| Est. Completion | 2024-04-17 |
| Phase | NA |
What the finished NCT05666245 record still lists
NCT05666245 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 4 interventions - of which Personal Protective Equipment (PPE) - Under High Air Hygiene is the first listed.
NCT05666245 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05666245 about?
NCT05666245 is a clinical study titled "DMID 21-0041; Influenza CVD 59000". The primary objective of EMIT-2 is to use a randomized controlled trial (RCT) design to implement interventions which are known to reduce inhalation (airborne) transmission, so that the contribution of transmission by route of aerosols for influenza may be identified.
What is the current status of trial NCT05666245?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2023-02-20. Estimated completion is 2024-04-17.
What interventions are being tested in trial NCT05666245?
The interventions under investigation include: Personal Protective Equipment (PPE) - Under High Air Hygiene (BEHAVIORAL), No Intervention - Under High Air Hygiene (BEHAVIORAL), Personal Protective Equipment (PPE) - Under Low Air Hygiene (BEHAVIORAL), No Intervention - Under Low Air Hygiene (BEHAVIORAL).
Who is sponsoring clinical trial NCT05666245?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05666245's enrollment target sits among peer trials
34 1570th of 2000 higher than 427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI